Skip to content

D-chiro-inositol and Endometrial Thickness

The Effects of D-chiro-inositol in Endometrial Thickness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05283642
Enrollment
13
Registered
2022-03-17
Start date
2022-03-08
Completion date
2022-12-20
Last updated
2022-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Diseases

Brief summary

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.

Interventions

DIETARY_SUPPLEMENTDCI

Oral supplementation with D-chiro-inositol once daily

Sponsors

Lo.Li.Pharma s.r.l
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

\- altered endometrial thickness

Exclusion criteria

* patients with cancer * patients under hormonal treatments (progestogens and/or estrogens) * patients supplemented with inositols

Design outcomes

Primary

MeasureTime frameDescription
Change in endometrial thicknessTwo time points: baseline and after three monthsChange in endometrial thickness by ultrasound measurement from baseline to three months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026